World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
77
Citations
21819
World Ranking
1111
National Ranking
574

Adrienne D. Cox publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Adrienne D. Cox sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 186 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Adrienne D. Cox D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Adrienne D. Cox sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 77 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Adrienne D. Cox is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with significant contributions also made to Molecular Biology, Oncology, Cell Biology, Pathology and Forensic Medicine, and Epidemiology.

Their work covers multiple main topics including:

  • Protein Kinase Regulation and GTPase Signaling
  • Melanoma and MAPK Pathways
  • Pancreatic and Hepatic Oncology Research
  • PI3K/AKT/mTOR signaling in cancer
  • Autophagy in Disease and Therapy
  • Cancer Mechanisms and Therapy
  • Peptidase Inhibition and Analysis

Adrienne D. Cox has published extensively in a range of scientific journals. Frequent publication venues include:

  • UNC Libraries
  • Cancer Research
  • Molecular Cancer Research
  • Science
  • Cell Reports

Recent papers provide insight into their research focus and collaboration. Notable recent publications include:

  • "Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer" (2022, Cancer Research)
  • "Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers" (2020, Cell Reports)
  • "Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers" (2024, Science)
  • "TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors" (2023, Cancer Research)
  • "Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer" (2024, Science)

The scientist has frequently collaborated with a select group of coauthors, including:

  • Channing J. Der
  • Clint A. Stalnecker
  • Kirsten L. Bryant
  • Andrew M. Waters
  • Mariaelena Pierobon

Best Publications

  • Drugging the undruggable Ras: mission possible?

    Adrienne D. Cox;Stephen W. Fesik;Alec C. Kimmelman;Ji Luo

  • Ras history: The saga continues.

    Adrienne D. Cox;Channing J. Der

  • Ras signalling on the endoplasmic reticulum and the Golgi.

    Vi K. Chiu;Trever Bivona;Angela Hach;J. Bernard Sajous

  • Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity

    Kiyoko Kato;Adrienne D. Cox;Adrienne D. Cox;Mark M. Hisaka;Mark M. Hisaka;Suzanne M. Graham;Suzanne M. Graham

  • The dark side of Ras: regulation of apoptosis

    Adrienne D Cox;Channing J Der

  • Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

    Kirsten L. Bryant;Clint A. Stalnecker;Daniel Zeitouni;Jennifer E. Klomp

  • PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis.

    Trever G. Bivona;Steven E. Quatela;Brian O. Bodemann;Ian M. Ahearn

  • Phospholipase Cγ activates Ras on the Golgi apparatus by means of RasGRP1

    Trever G. Bivona;Ignacio Pérez de Castro;Ian M. Ahearn;Theresa M. Grana

  • Rab1b regulates vesicular transport between the endoplasmic reticulum and successive Golgi compartments.

    H Plutner;A D Cox;S Pind;R Khosravi-Far

  • Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes.

    Edwina C. Lerner;Yimin Qian;Michelle A. Blaskovich;Renae D. Fossum

  • Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome

    Brian C. Capell;Michael R. Erdos;James P. Madigan;James J. Fiordalisi

  • Activation of RalA is critical for Ras-induced tumorigenesis of human cells

    Kian Huat Lim;Antonio T. Baines;James J. Fiordalisi;Michail Shipitsin

  • Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification

    Patrick J. Roberts;Natalia Mitin;Patricia J. Keller;Emily J. Chenette

  • RALA and RALBP1 regulate mitochondrial fission at mitosis

    David F. Kashatus;Kian Huat Lim;Kian Huat Lim;Donita C. Brady;Donita C. Brady;Nicole L.K. Pershing

  • Farnesyltransferase inhibitors and cancer treatment: Targeting simply ras?

    Adrienne D Cox;Channing J Der

  • Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?

    Adrienne D. Cox;Channing J. Der;Mark R. Philips

  • Protein prenylation: more than just glue?

    Adrienne D. Cox;Channing J. Der

  • Biological assays for Ras transformation.

    Geoffrey J. Clark;Adrienne D. Cox;Suzanne M. Graham;Channing J. Der

  • PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.

    James J. Fiordalisi;Patricia J. Keller;Adrienne D. Cox

  • L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases.

    J. M. Rhoads;R. A. Argenzio;W. Chen;R. A. Rippe

Frequent Co-Authors

Channing J. Der
Channing J. Der University of North Carolina at Chapel Hill
Lee M. Graves
Lee M. Graves University of North Carolina at Chapel Hill
Mark R. Philips
Mark R. Philips New York University
Yoel Kloog
Yoel Kloog Tel Aviv University
Emanuel F. Petricoin
Emanuel F. Petricoin George Mason University
Otto Zhou
Otto Zhou University of North Carolina at Chapel Hill
Roya Khosravi-Far
Roya Khosravi-Far Beth Israel Deaconess Medical Center
Agnieszka K. Witkiewicz
Agnieszka K. Witkiewicz Roswell Park Cancer Institute
Sharon L. Campbell
Sharon L. Campbell University of North Carolina at Chapel Hill
John Westwick
John Westwick Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA opens doors to many diverse career pathways, especially in the fast-growing healthcare sector. Today’s students often consider flexible, online degree options that support faster entry into medical professions or career advancement. For example, nurses looking to build on their education may consider a 6-month rn to bsn program, designed for working professionals seeking quick degree completion.

Similarly, those interested in progressing from a registered nurse to a nurse practitioner can explore an adn to np program, which bridges the gap to advanced nursing credentials and expanded roles. Non-nursing graduates eager to transition into nursing may benefit from direct entry msn programs that accept applicants from a variety of scientific backgrounds, including molecular biology.

With multiple universities offering online healthcare degrees, researching programs is essential. Comparisons like capella university vs wgu rn to bsn can help you evaluate flexibility, cost, and reputation, ensuring you find the right fit for your educational and career goals in this ever-evolving field.

Best Scientists Citing Adrienne D. Cox

Trending Scientists

Recently Published Articles